Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| CRINETICS PHARMACEUTICALS | 3 | - | +0,50 % | ||
| BIONTECH | 2 | 13 | -0,06 % | ||
| ANAVEX LIFE SCIENCES | 1 | - | -2,70 % | ||
| BIOGEN | - | 54 | -0,53 % | ||
| AMGEN | - | 27 | -0,16 % | ||
| INCYTE | - | 25 | -1,69 % | ||
| REGENERON PHARMACEUTICALS | - | 22 | -0,36 % | ||
| MONTE ROSA THERAPEUTICS | - | 21 | -2,36 % | ||
| EYEPOINT | - | 20 | -1,24 % | ||
| NEUROCRINE BIOSCIENCES | - | 17 | -0,67 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| So | Crinetics kündigt Telefonkonferenz zu neuen Daten von Paltusotin und Atumelnant an | 1 | Investing.com Deutsch | ||
| So | Crinetics to host conference call on paltusotine and atumelnant data | 1 | Investing.com | ||
| So | Crinetics Pharmaceuticals, Inc.: Crinetics Pharmaceuticals to Provide PALSONIFY Business Update and Announce Topline Results from Fourth Cohort of Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia | 2 | GlobeNewswire (USA) | ||
| So | ANAVEX LIFE SCIENCES CORP steht vor explosivem Moment | 1 | Maximilian Berger | ||
| So | Wochenend-Update: Biontech-Aktie im Fokus - was Anleger jetzt wissen müssen! | Hebelschein-Spekulant | |||
| Sa | Benzinga Bulls And Bears: Nike, SpaceX, Ultragenyx - And Chinese Tech Stocks Slide | 9 | Benzinga.com | ||
| Sa | GH Research surges on upcoming late-stage trial update | 3 | Seeking Alpha | ||
| Fr | Rani Therapeutics ändert Satzung, reduziert Stimmrechte und beendet Steuerabkommen | 1 | Investing.com Deutsch | ||
| Fr | GH Research: Aktie schießt nach Ankündigung zu Medikamenten-Update in die Höhe | 2 | Investing.com Deutsch | ||
| Fr | Alumis wirft Climb Bio Vertragsbruch wegen verweigerter Meilensteinzahlung vor | 3 | Investing.com Deutsch | ||
| Fr | Rani Therapeutics Holdings, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| Fr | GH Research: Update zum FDA-Zulassungsantrag für Depressionsmedikament angekündigt | 4 | Investing.com Deutsch | ||
| Fr | Terns Pharmaceuticals, Inc.: Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) | 4 | GlobeNewswire (USA) | ||
| Fr | Tenaya Therapeutics, Inc. - 8-K, Current Report | - | SEC Filings | ||
| Fr | Intellia Therapeutics, Inc.: Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 13 | GlobeNewswire (USA) | ||
| Fr | GH Research to provide update on FDA application for depression drug | 1 | Investing.com | ||
| Fr | GH Research PLC: GH Research to Announce IND Status for GH001 | 1 | GlobeNewswire (USA) | ||
| Fr | BridgeBio Pharma: Aktie markiert Rekordhoch bei 78,46 USD | 8 | Investing.com Deutsch | ||
| Fr | Arcellx, Inc. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| Fr | GH Research PLC - 6-K, Report of foreign issuer | - | SEC Filings |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .